Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Obstetric Medicine
|
August 12, 2016
Severe gestational hypertriglyceridemia: A practical approach for clinicians
Bertha Wong, Teik C Ooi, Erin Keely
Journal of Clinical Lipidology
|
October 9, 2020
Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers
Cathy J Sun, Diane Brisson, Daniel Gaudet, et al.
Canadian Journal of Diabetes
|
June 19, 2022
A More Atherogenic Lipoprotein Status Is Present in Adults With Type 2 Diabetes Mellitus Than in Those Without With Equivalent Degrees of Hypertriglyceridemia
Cathy J Sun, Diane Brisson, Rahul Sharma, et al.
The Canadian Journal of Cardiology
|
December 31, 2022
Comparison of Three Methods for LDLC Calculation for Cardiovascular Disease Risk Categorisation in Three Distinct Patient Populations
Cathy J Sun, Christopher McCudden, Diane Brisson, et al.
Journal of the Endocrine Society
|
February 4, 2020
Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
Cathy J Sun, Christopher McCudden, Diane Brisson, et al.
Obesity (Silver Spring, Md.)
|
September 25, 2016
The anti-adipogenic effect of peripheral blood mononuclear cells is absent with PCSK9 loss-of-function variants
AnneMarie Gagnon, Teik C Ooi, Marion Cousins, et al.
Metabolism: Clinical and Experimental
|
September 16, 2015
The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype
Jean-Philippe Drouin-Chartier, André J Tremblay, Jean-Charles Hogue, et al.
Systematic Reviews
|
June 2, 2012
Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review
Salmaan Kanji, Dugald Seely, Fatemeh Yazdi, et al.
Current Vascular Pharmacology
|
July 17, 2019
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
Genovefa D Kolovou, Gerald F Watts, Dimitri P Mikhailidis, et al.
Current Vascular Pharmacology
|
May 8, 2019
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
Genovefa D Kolovou, Gerald F Watts, Dimitri P Mikhailidis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Obstetric Medicine
|
August 12, 2016
Severe gestational hypertriglyceridemia: A practical approach for clinicians
Bertha Wong, Teik C Ooi, Erin Keely
Journal of Clinical Lipidology
|
October 9, 2020
Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers
Cathy J Sun, Diane Brisson, Daniel Gaudet, et al.
Canadian Journal of Diabetes
|
June 19, 2022
A More Atherogenic Lipoprotein Status Is Present in Adults With Type 2 Diabetes Mellitus Than in Those Without With Equivalent Degrees of Hypertriglyceridemia
Cathy J Sun, Diane Brisson, Rahul Sharma, et al.
The Canadian Journal of Cardiology
|
December 31, 2022
Comparison of Three Methods for LDLC Calculation for Cardiovascular Disease Risk Categorisation in Three Distinct Patient Populations
Cathy J Sun, Christopher McCudden, Diane Brisson, et al.
Journal of the Endocrine Society
|
February 4, 2020
Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
Cathy J Sun, Christopher McCudden, Diane Brisson, et al.
Obesity (Silver Spring, Md.)
|
September 25, 2016
The anti-adipogenic effect of peripheral blood mononuclear cells is absent with PCSK9 loss-of-function variants
AnneMarie Gagnon, Teik C Ooi, Marion Cousins, et al.
Metabolism: Clinical and Experimental
|
September 16, 2015
The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype
Jean-Philippe Drouin-Chartier, André J Tremblay, Jean-Charles Hogue, et al.
Systematic Reviews
|
June 2, 2012
Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review
Salmaan Kanji, Dugald Seely, Fatemeh Yazdi, et al.
Current Vascular Pharmacology
|
July 17, 2019
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
Genovefa D Kolovou, Gerald F Watts, Dimitri P Mikhailidis, et al.
Current Vascular Pharmacology
|
May 8, 2019
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
Genovefa D Kolovou, Gerald F Watts, Dimitri P Mikhailidis, et al.
Page
of 2